Fast Money Traders Share Their Picks For Trump's Next 100 Days

Guy Adami believes iShares NASDAQ Biotechnology Index (ETF) IBB should perform well. He added the risk-reward in Financial Select Sector SPDR Fund XLF looks attractive as well.

Dan Nathan would stick with Technology Select Sector SPDR Fund XLK, because the current administration is going to set up some sort of corporate tax reform that is going to help the large tech names. He also thinks XLK is going to benefit from repatriation. Nathan believes Apple Inc. AAPL is going to benefit the most.

Tim Seymour believes the hype about corporate taxes and repatriation is overrated, because most U.S. corporations don't pay 35 percent taxes. He thinks XLF could have a lot of upside.